(SPAQ) Horizon Kinetics SPAC Active - Ratings and Ratios
Exchange: NASDAQ •
Country: USA •
Currency: USD •
Type: Etf •
ISIN: US53656G5559
SPAC Securities, Stocks, Healthcare Equities
Description: SPAQ Horizon Kinetics SPAC Active
The fund is an actively-managed exchange-traded fund that pursues its investment objective primarily by investing, under normal circumstances, in special purpose acquisition companies ('SPACs') that, the fund's investment sub-adviser, believes will generate net realized capital gains in excess of the income derived from bank certificates of deposit with similar maturities. The fund is non-diversified.
SPAQ ETF Overview
Market Cap in USD | 13m |
Category | Health |
TER | 0.85% |
IPO / Inception | 2007-06-29 |
SPAQ ETF Ratings
Growth Rating | 79.1% |
Fundamental | - |
Dividend Rating | 56.6% |
Return 12m vs S&P 500 | -9.38% |
Analyst Rating | - |
SPAQ Dividends
Dividend Yield 12m | 2.90% |
Yield on Cost 5y | 3.30% |
Annual Growth 5y | 7.95% |
Payout Consistency | 100.0% |
Payout Ratio | % |
SPAQ Growth Ratios
Growth Correlation 3m | -77.2% |
Growth Correlation 12m | 96.3% |
Growth Correlation 5y | 98.6% |
CAGR 5y | 7.47% |
CAGR/Max DD 5y | 1.84 |
CAGR/Mean DD 5y | 51.30 |
Sharpe Ratio 12m | 0.33 |
Alpha | 3.07 |
Beta | 0.121 |
Volatility | 2.88% |
Current Volume | 0k |
Average Volume 20d | 0.1k |
Stop Loss | 100.8 (-3%) |
Signal | 0.08 |
What is the price of SPAQ shares?
As of September 09, 2025, the stock is trading at USD 103.95 with a total of 29 shares traded.
Over the past week, the price has changed by -0.01%, over one month by -0.28%, over three months by -0.84% and over the past year by +8.48%.
Over the past week, the price has changed by -0.01%, over one month by -0.28%, over three months by -0.84% and over the past year by +8.48%.
Is Horizon Kinetics SPAC Active a good stock to buy?
Yes. Based on ValueRay's Analyses, Horizon Kinetics SPAC Active (NASDAQ:SPAQ) is currently (September 2025)
a good stock to buy. It has a ValueRay Growth Rating of 79.10 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SPAQ is around 101.68 USD . This means that SPAQ is currently overvalued and has a potential downside of -2.18%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SPAQ is around 101.68 USD . This means that SPAQ is currently overvalued and has a potential downside of -2.18%.
Is SPAQ a buy, sell or hold?
Horizon Kinetics SPAC Active has no consensus analysts rating.
What are the forecasts/targets for the SPAQ price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 111.3 | 7.1% |
Last update: 2025-08-30 04:57
SPAQ Fundamental Data Overview
Market Cap USD = 13.3m (13.3m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.1044
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 13.3m USD (13.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 13.3m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 13.3m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(13.3m)/V(0.0) * Re(6.46%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 6.46% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.1044
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 13.3m USD (13.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 13.3m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 13.3m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(13.3m)/V(0.0) * Re(6.46%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 6.46% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for SPAQ ETF
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle